# Back Pain in Patients With Severe Osteoporosis

> **NCT00761332** · — · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 650 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** teriparatide
- **DRUG:** antiresorptives

## Key facts

- **NCT ID:** NCT00761332
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 650 (ACTUAL)
- **Last updated:** 2011-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00761332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00761332, "Back Pain in Patients With Severe Osteoporosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00761332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*